
Our International Products
Products Category
Anti Viral
Therapeutic | Products Name | Molecule / Composition | Type | Indications |
---|---|---|---|---|
Anti Virals | Abacavir | 300 mg | Tablet | Indicated for the treatment of HIV-1 infection in combination with other ARV agents, it is primarily used to reduce viral load and increase CD4 cell counts in HIV-positive individuals. |
Anti Virals | Abacavir + Lamivudine | 300 mg + 150 mg, 600 mg + 30 mg | Tablet | Prescribed together to treat HIV-1 infection in both adults and children, which when combined with other ARV medications, this therapy helps lower viral levels and enhance immune response. |
Anti Virals | Abacavir + Lamivudine + Dolutegravir | 600 mg + 300 mg + 50 mg | Tablet | Indicated for the treatment of HIV-1 infection in adults and children weighing at least 10 kg, it is used to suppress viral replication and improve immune function |
Anti Virals | Abacavir + Lamivudine + Zidovudine | 300 mg + 150 mg + 300 mg | Tablet | Prescribed for treating HIV-1 infection in both adults and children, it is used to lower viral load and boost CD4 cell counts. |
Anti Virals | Aciclovir | 5% | Cream | Indicated for the topical treatment of herpes simplex virus infections, including cold sores (herpes labialis) and genital herpes; it works by inhibiting viral DNA synthesis. |
Anti Virals | Aciclovir | 200 mg | Tablet | Indicated for the systemic treatment of infections caused by the herpes simplex virus, including genital herpes, herpes zoster (shingles), and varicella (chickenpox). |
Anti Virals | Arbidol | 100 mg | Tablet | Indicated for the prevention and treatment of influenza and other respiratory viral infections caused by viruses such as influenza A and B. |
Anti Virals | Atazanavir | 100 mg, 150 mg, 200 mg, 300 mg | Capsule | Indicated for the treatment of HIV-1 infection in adults and children; it works by preventing the cleavage of viral polyproteins into functional proteins, thereby reducing viral replication. |
Anti Virals | Atazanavir + Ritonavir | 300 mg + 100 mg | Tablet | Indicated for the treatment of HIV-1 infection in adults and pediatric patients, improving antiviral efficacy and supporting viral load reduction. |
Anti Virals | Darunavir | 300 mg, 600 mg | Tablet | Indicated for the treatment of HIV-1 infection in adults and pediatric patients, darunavir impedes viral replication. |
Anti Virals | Didanosine Delayed Release | 400 mg | Capsule | Indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents as part of a comprehensive antiretroviral therapy regimen. |
Anti Virals | Dolutegravir | 50 mg | Tablet | Indicated for the treatment of HIV infection in adults and children, it prevents viral replication |
Anti Virals | Efavirenz | 600 mg | Tablet | Indicated for the treatment of HIV-1 infection infection in adults and children, efavirenz works by reducing viral replication. |
Anti Virals | Emtricitabine | 200 mg | Capsule | Indicated for the treatment of HIV-1 infection in adults and pediatric patients, emtricitabine works by reducing viral load. |
Anti Virals | Entecavir | 0.5 mg, 1 mg | Tablet | Indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults and pediatric patients with evidence of active viral replication and liver inflammation. |
Anti Virals | Etravirine | 100 mg, 200 mg | Tablet | Indicated for the treatment of HIV-1 infection in adults and pediatric patients who are treatment-experienced and have a history of virologic failure. |
Anti Virals | Favipiravir | 200 mg, 400 mg, 600 mg | Tablet | Indicated for the treatment of influenza and other viral infections, including novel viral outbreaks, where antiviral therapy is deemed necessary. |
Anti Virals | Fosamprenavir | 700 mg | Tablet | Indicated for the treatment of HIV-1 infection in adults and pediatric patients, used as part of a comprehensive antiretroviral therapy regimen. |
Anti Virals | Lamivudine | 100 mg, 150 mg, 300 mg | Tablet | Indicated for the treatment of HIV-1 infection in adults and pediatric patients, typically as part of a combination ARV therapy regimen. Additionally, lamivudine is used in the management of chronic hepatitis B virus (HBV) infection. |
Anti Virals | Lamivudine + Tenofovir | 900 mg | Tablet | Indicated for the treatment of HIV-1 infection in adults and pediatric patients, used as part of a comprehensive ARV therapy regimen. Lamivudine inhibits viral replication Tenofovir prevents its synthesis. |
Anti Virals | Lamivudine + Zidovudine | 450 mg, 900 mg | Tablet | Indicated for the treatment of HIV-1 infection in adults and children as part of a comprehensive ARV therapy regimen, Lamivudine and Zidovudine work synergistically to inhibit viral replication. |
Anti Virals | Lamivudine + Zidovudine + Nevirapine | 30 mg + 60 mg + 50 mg, 150 mg + 300 mg + 250 mg | Tablet | Indicated for the treatment of HIV-1 infection in adults and pediatric patients as part of an antiretroviral therapy regimen. Lamivudine and zidovudine inhibit viral replication Nevirapine reduces viral load. |
Anti Virals | Lopinavir + Ritonavir | 100 mg/ ml | Solution | Indicated for the treatment of HIV-1 infection in adults and pediatric patients, used as part of a comprehensive ARV therapy regimen. |
Anti Virals | Lopinavir + Ritonavir | 50 mg, 125 mg, 250 mg | Tablet | Indicated for the treatment of HIV-1 infection in adults and pediatric patients, used as part of a comprehensive ARV therapy regimen. |
Anti Virals | Molnupiravir | 200 mg | Capsule | Indicated for the treatment of mild to moderate COVID-19 in adults who are at high risk of progressing to severe disease or hospitalization. |
Anti Virals | Nelfinavir | 50 mg/ gm | Dry Syrup | Indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents as part of a comprehensive antiretroviral therapy regimen. |
Anti Virals | Nelfinavir | 250 mg, 625 mg | Tablet | Indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents as part of a comprehensive antiretroviral therapy regimen. |
Anti Virals | Nevirapine | 200 mg | Tablet | Indicated for the treatment of HIV-1 infection in combination with other ARV agents, nevirapine reduces viral replication and improves immune function in affected patients. |
Anti Virals | Oseltamavir | 75 mg | Capsule | Indicated for the treatment and prophylaxis of influenza virus infection in adults and pediatric patients. |
Anti Virals | Raltegravir | 100 mg, 400 mg | Tablet | Indicated for the treatment of HIV-1 infection in adults and pediatric patients as part of a comprehensive ARV therapy regimen. |
Anti Virals | Ribavirin | 200 mg, 400 mg | Capsule | Indicated for the treatment of chronic hepatitis C virus (HCV) infection, often used in combination with direct-acting antiviral agents or pegylated interferon to enhance antiviral efficacy. |
Anti Virals | Rimantadine | 10 mg/ 5ml | Syrup | Indicated for the prophylaxis and treatment of influenza A virus infections, particularly in children and high-risk populations. |
Anti Virals | Ritonavir | 100 mg | Capsule | Indicated for the treatment of HIV-1 infection in combination with other ARV agents as part of a comprehensive therapy regimen. |
Anti Virals | Ritonavir | 100 mg | Tablet | Indicated for the treatment of HIV-1 infection in combination with other ARV agents as part of a comprehensive therapy regimen. |
Anti Virals | Sofosbuvir | 400 mg | Tablet | Indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults, often used in combination with other direct-acting antiviral agents, Sofosbuvir leads to a reduction in viral load. |
Anti Virals | Stavudine | 30 mg, 40 mg | Capsule | Indicated for the treatment of HIV infection as part of a comprehensive antiretroviral therapy regimen in both adults and children. |
Anti Virals | Tenofovir Disoproxil Fumarate | 300 mg | Tablet | Indicated for the treatment of HIV-1 infection in combination with other ARV agents and for the treatment of chronic hepatitis B virus (HBV) infection. |
Anti Virals | Tenofovir Disoproxil Fumarate + Emtricitabine | 300 mg + 200 mg | Tablet | Indicated for the treatment of HIV-1 infection in adults and pediatric patients, as part of a comprehensive antiretroviral therapy regimen. Tenofovir disoproxil fumarate interferes with viral RNA replication Emtricitabine prevents the conversion of viral RNA into DNA. |
Anti Virals | Tenofovir + Emtricitabine + Efavirenz | 300 mg + 200 mg + 600 mg | Tablet | Indicated for the treatment of human immunodeficiency virus (HIV-1) infection in adults and children as part of a comprehensive antiretroviral therapy regimen. Tenofovir and emtricitabine inhibit viral replication by incorporating into the viral DNA Efavirenz disrupts the viral lifecycle and effectively reducing viral load in infected patients. |
Anti Virals | Tenofovir + Lamivudine + Dolutegravir | 300 mg + 300 mg + 50 mg | Tablet | Indicated for the treatment of HIV-1 infection in adults and pediatric patients, serving as part of a comprehensive antiretroviral therapy regimen. Tenofovir and lamivudine inhibit viral RNA transcription into DNA Dolutegravir prevents the integration of viral DNA into the host genome. |
Anti Virals | Tenofovir + Lamivudine + Efavirenz | 300 mg + 300 mg + 400 mg | Tablet | Indicated for the treatment of HIV-1 infection in adults and children as part of a comprehensive antiretroviral therapy regimen. Tenofovir and lamivudine inhibit viral reverse transcription Efavirenz disrupts viral replication. |
Anti Virals | Valacyclovir | 500 mg, 1000 mg | Tablet | Indicated for the treatment of infections caused by herpes simplex virus (HSV) and varicella-zoster virus (VZV), including the management of genital herpes, cold sores, and shingles (herpes zoster). |
Anti Virals | Valganciclovir | 450 mg | Tablet | Indicated for the prevention and treatment of cytomegalovirus (CMV) infections and diseases in immunocompromised patients, including those undergoing organ transplantation and individuals with acquired immunodeficiency syndrome (AIDS). |
Anti Virals | Zidovudine | 100 mg, 300 mg | Tablet | Indicated for the treatment of HIV in adults and children, often used in combination with other ARV agents as part of a comprehensive ARV therapy regimen. |
Anti Inflammatory
Therapeutic | Products Name | Molecule / Composition | Type | Indications |
---|---|---|---|---|
Anti Inflammatory | Acelofenac | 50 mg 100 mg | Tablet | Indicated for the relief of pain and inflammation in conditions like osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, it helps reduce swelling, stiffness, and joint pain. |
Anti Inflammatory | Deflazacort | 6 mg/ 5 ml | Suspension | Indicated for the treatment of various inflammatory and autoimmune conditions, including rheumatoid arthritis, systemic lupus erythematosus, and certain skin disorders, deflazacort exerts its anti-inflammatory effects. |
Anti Inflammatory | Diclofenac diethylamine + Linseed oil + Methyl Salicylate + Menthol | 1% + 3% + 10% + 5% | Gel | Indicated for the topical management of pain and inflammation associated with musculoskeletal disorders, such as osteoarthritis, rheumatoid arthritis, and localized muscle pain. Diclofenac diethylamine reduces inflammation and pain. Methyl salicylate provides analgesic properties, Linseed oil offers a soothing effect, Menthol imparts a cooling sensation. |
Anti Inflammatory | Diclofenc Potassium + Paracetamol | 50 mg + 500 mg | Tablet | Indicated for the management of mild to moderate pain and inflammation associated with various conditions, such as osteoarthritis, rheumatoid arthritis, and postoperative pain. Diclofenac Potassium reduces inflammation and pain, Paracetamol provides additional analgesic and antipyretic effects. |
Anti Inflammatory | Diclofenc Potassium + Paracetamol + Serratiopeptidase | 50 mg + 500 mg + 15 mg | Tablet | Indicated for the management of pain and inflammation associated with various conditions, including musculoskeletal disorders, postoperative pain, and sports injuries. Diclofenac sodium serves as a NSAID, Paracetamol provides analgesic and antipyretic effects, Serratiopeptidase helps reduce swelling and facilitates tissue repair. |
Anti Inflammatory | Ibuprofen | 2.5% 5% | Gel | Indicated for the treatment and prevention of malaria, as well as for the management of autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus. |
Anti Inflammatory | Ibuprofen | 100 mg/5 ml | Suspension | Indicated for the treatment and prevention of malaria, as well as for the management of autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus. |
Anti Inflammatory | Ibuprofen | 400 mg | Tablet | Indicated for the relief of mild to moderate pain, inflammation, and fever associated with various conditions such as osteoarthritis, rheumatoid arthritis, dysmenorrhea, and dental pain, ibuprofen exerts its analgesic and anti-inflammatory effects. |
Anti Inflammatory | Ibuprofen SR | 400 mg | Capsule | Indicated for the management of pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, and dysmenorrhea. |
Anti Inflammatory | Ketoprofen | 2.5% 5% | Gel | Indicated for the topical management of pain and inflammation associated with musculoskeletal disorders, such as osteoarthritis, rheumatoid arthritis, and localized soft tissue injuries. |
Anti Inflammatory | Meloxicam | 1% | Gel | Indicated for the topical management of pain and inflammation associated with musculoskeletal disorders, such as osteoarthritis and rheumatoid arthritis. |
Anti Inflammatory | Nimesulide | 10 mg | Gel | Indicated for the management of acute and chronic pain, including conditions such as osteoarthritis, rheumatoid arthritis, and dysmenorrhea. |
Anti Inflammatory | Nimesulide + Paracetamol | 100 mg + 325 mg | Tablet | Indicated for the symptomatic relief of pain and inflammation associated with various conditions, including osteoarthritis, dysmenorrhea, and postoperative pain. Nimesulide acts as an NSAID, Paracetamol provides additional analgesic and antipyretic effects. |
Anti Inflammatory | Paracetamol + Ibuprofen + Caffeine | 325 mg + 200 mg + 30 mg | Capsule | Indicated for the relief of mild to moderate pain, including headaches, migraines, and musculoskeletal pain, as well as for the reduction of fever. Paracetamol and ibuprofen provide synergistic analgesic and anti-inflammatory effects, Caffeine enhances the analgesic properties of both drugs by promoting vasodilation and increasing the absorption of paracetamol. |
Anti Inflammatory | Aspirin | 75 mg | Tablet | Indicated for the prevention and treatment of cardiovascular diseases, including myocardial infarction and stroke, due to their antiplatelet effects. |
Dermatology
Therapeutic | Products Name | Molecule / Composition | Type | Indications |
---|---|---|---|---|
Dermatology | Acitretin | 25 mg | Capsule | Indicated for the treatment of severe psoriasis and other keratinization disorders, such as ichthyosis, by modulating cellular proliferation and differentiation, leading to a reduction in hyperkeratosis. |
Dermatology | Beclomethasone Dipropionate + Clotrimazole + Gentamicin | 0.025% + 1% + 0.1% | Cream | Indicated for the topical treatment of inflammatory skin conditions complicated by fungal and bacterial infections, such as dermatitis and eczema. Beclomethasone dipropionate reduces inflammation and itching, Clotrimazole acts as an antifungal agent, Gentamicin provides antibacterial activity. |
Dermatology | Betamethasone Dipropionate | 0.05% | Ointment | Indicated for the topical treatment of inflammatory and pruritic manifestations such as psoriasis, eczema, and lichen planus. It reduces inflammation, erythema, and itching by inhibiting the release of inflammatory mediators. |
Dermatology | Betamethasone Dipropionate + Clotrimazole + Gentamicin | 0.05% + 1% + 0.1% | Cream | Indicated for the topical treatment of inflammatory skin conditions of fungal and bacterial infections, such as dermatitis or psoriasis. Betamethasone dipropionate alleviates inflammation and pruritus, Clotrimazole provides antifungal activity, Gentamicin exerts antibacterial effects. |
Dermatology | Betamethasone Valerate | 0.1% | Cream | Indicated for the topical treatment of inflammatory skin disorders, such as eczema, psoriasis etc., it works by inhibiting the inflammatory response, reducing erythema, pruritus, and swelling. |
Dermatology | Clobetasol | 0.05% | Cream | Indicated for the topical treatment of inflammatory skin disorders, such as psoriasis, eczema, dermatitis, etc., clobetasol works by inhibiting the inflammatory response, reducing erythema, pruritus, and swelling. |
Dermatology | Clotrimazole | 1% , 2% | Cream | Indicated for the topical treatment of superficial fungal infections, including tinea (athlete’s foot, jock itch, and ringworm), candidiasis, and other dermatophyte infections. |
Dermatology | Clotrimazole | 100 mg | Tablet | Indicated for the treatment of various fungal infections, particularly those caused by Candida species and dermatophytes, including oropharyngeal candidiasis (thrush) and vulvovaginal candidiasis. |
Dermatology | Dexpanthenol | 5% | Ointment | Indicated for the topical treatment of skin conditions requiring moisturizing and healing, such as dry skin, dermatitis, and minor wounds, dexpanthenol enhances skin hydration. |
Dermatology | Dexpanthenol + Chlorhexidine | 5% + 0.5% | Cream | Indicated for the prevention and treatment of skin infections, such as abrasions, cuts, and dermatitis. Dexpanthenol acts as a moisturizing and healing agent promoting skin regeneration and hydration, Chlorhexidine provides antimicrobial activity. |
Dermatology | Fluconazole | 50 mg 150 mg 200 mg | Capsule | Indicated for the treatment and prophylaxis of fungal infections, including oropharyngeal candidiasis, esophageal candidiasis, and systemic candidiasis, as well as for the management of cryptococcal meningitis in immunocompromised patients. |
Dermatology | Fluocinolone Acetonide | 0.025% | Ointment | Indicated for the topical treatment of inflammatory skin disorders, such as eczema, dermatitis, psoriasis etc. Fluocinolone acetonide exerts anti-inflammatory, antipruritic, and vasoconstrictive effects. |
Dermatology | Itraconazole | 100 mg | Capsule | Indicated for the treatment of various fungal infections, including onychomycosis, histoplasmosis, blastomycosis, and aspergillosis, particularly in immunocompromised patients. |
Dermatology | Lidocaine + Prilocaine | 2.5% + 2.5% | Cream | Indicated for the topical anesthesia of intact skin prior to minor dermatological procedures, such as venipuncture, laser surgery, and skin grafts, this cream provides effective pain relief in the area of application. |
Dermatology | Mometasone Furoate | 0.1% | Cream | Indicated for the topical treatment of inflammatory and pruritic manifestations of dermatoses, such as psoriasis, eczema, and contact dermatitis, mometasone furoate reduces inflammation, itching, and redness. |
Dermatology | Naftifine Hydrochloride | 1% | Cream | Indicated for the topical treatment of superficial fungal infections, including tinea pedis (athlete’s foot), tinea cruris (jock itch), and tinea corporis (ringworm). |
Dermatology | Terbinafine | 1% | Gel | Indicated for the topical treatment of superficial dermatophyte infections, such as tinea pedis (athlete’s foot), tinea cruris (jock itch), and tinea corporis (ringworm). |
Dermatology | Terbinafine | 1% | Cream | Indicated for the topical treatment of superficial dermatophyte infections, such as tinea pedis (athlete’s foot), tinea cruris (jock itch), and tinea corporis (ringworm). |
Dermatology | Terbinafine | 250 mg | Tablet | Indicated for the treatment of systemic fungal infections, particularly dermatophyte infections such as onychomycosis (fungal nail infections) and tinea capitis. |
Dermatology | Ternidazole + Neomycin + Nystatin + Prednisolone | 200 mg + 100 mg + 100000 IU + 3 mg | Tablet | Indicated for the treatment of mixed infections involving anaerobic bacteria, fungi, and inflammation, such as those seen in certain dermatological and otic conditions. Ternidazole provides antifungal activity, Neomycin acts as an antibiotic, Nystatin offers additional antifungal coverage, and Prednisolone reduces inflammation and immune response. |
Dermatology | Zinc Oxide | 20.63% | Ointment | Indicated for the topical treatment of various skin conditions, including diaper dermatitis, eczema, and minor skin irritations. |
Dermatology | Zinc pyrithione | 0.2% | Cream | Indicated for the treatment of various skin conditions characterized by excessive scaling and inflammation, such as seborrheic dermatitis, dandruff, and psoriasis. |
Anti Parasitic
Therapeutic | Products Name | Molecule / Composition | Type | Indications |
---|---|---|---|---|
Anti Parasitic | Albendazole | 100 mg/5ml 200 mg/5ml | Suspension | Indicated for the treatment of various helminthic infections, including ascariasis, enterobiasis, etc. by inhibiting microtubule synthesis in parasites, leading to their immobilization and death. |
Anti Parasitic | Albendazole | 200 mg 400 mg | Tablet | Indicated for the treatment of various helminthic infections, including ascariasis, enterobiasis, etc. by inhibiting microtubule synthesis in parasites, leading to their immobilization and death. |
Anti Parasitic | Ivermectin | 6mg | Tablet | Indicated for the treatment of various parasitic infections, including strongyloidiasis, onchocerciasis (river blindness), and lymphatic filariasis, ivermectin leads to paralysis and death of the parasites. |
Anti Parasitic | Pyrantel Pamoate | 250 mg/ 5 ml | Suspension | Indicated for the treatment of various intestinal parasitic infections, particularly those caused by roundworms such as Enterobius vermicularis (pinworm), Ascaris lumbricoides (large roundworm), and Ancylostoma duodenale (hookworm). |
Anti Parasitic | Pyrantel Pamoate | 250 mg | Tablet | Indicated for the treatment of various intestinal parasitic infections, particularly those caused by roundworms such as Enterobius vermicularis (pinworm), Ascaris lumbricoides (large roundworm), and Ancylostoma duodenale (hookworm). |
Gastroenterology
Therapeutic | Products Name | Molecule / Composition | Type | Indications |
---|---|---|---|---|
Gastroenterology | Alumina + Magnesia | 200 mg + 200 mg | Suspension | Indicated for the symptomatic relief of GERD, heartburn, and indigestion. Alumina acts as an antacid that neutralizes stomach acid, Magnesia provides additional antacid properties and promotes bowel regularity. |
Gastroenterology | Alumina + Magnesia + Simethicone | 200 mg + 200 mg + 25 mg 250 mg + 1.14 mg + 50 mg | Suspension | Indicated for the symptomatic relief of dyspepsia, heartburn, and acid indigestion. Alumina and magnesia act as antacids to neutralize gastric acid and reduce acidity in the stomach, while simethicone functions as an anti-foaming agent. |
Gastroenterology | Esomeprazole | 20 mg 40 mg | Tablet | Indicated for the treatment of GERD, peptic ulcers, and Zollinger-Ellison syndrome, as well as for the prevention of gastric ulcers associated with NSAID use. |
Gastroenterology | Lactulose | 3.335 gm / 5 ml | Solution | Indicated for the treatment of chronic constipation and the prevention and management of hepatic encephalopathy in patients with liver disease, lactulose functions as an osmotic laxative by increasing the water content and volume of the intestinal contents, thereby promoting bowel movements. |
Gastroenterology | Lansoprazole Delayed-Release | 30 mg | Capsule | Indicated for the treatment of GERD, Zollinger-Ellison syndrome, and peptic ulcers. |
Gastroenterology | Omeprazole | 20 mg | Capsule | Indicated for the treatment of GERD, peptic ulcers, and Zollinger-Ellison syndrome, as well as for the eradication of Helicobacter pylori in combination therapy for peptic ulcer disease. |
Gastroenterology | Ondansetron Hydrochloride | 2 mg/ 5 ml | Syrup | Indicated for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery. |
Gastroenterology | Pantoprazole Sodium Delayed Release | 40 mg | Tablet | Indicated for the treatment of GERD, erosive esophagitis, and Zollinger-Ellison syndrome, pantoprazole decreases gastric acid secretion, which promotes healing of the esophagus and alleviates symptoms associated with excessive acid production. |
Gastroenterology | Pantoprazole + Domperidone SR | 20 mg 40 mg | Capsule | Indicated for the management of GERD, peptic ulcers, and other acid-related disorders. Pantoprazole reduces gastric acid secretion Domperidone enhances gastrointestinal motility and alleviates nausea and vomiting. |
Gastroenterology | Rabeprazole | 10 mg 20 mg | Tablet | Indicated for the treatment of GERD, peptic ulcers, and Zollinger-Ellison syndrome. |
Respiratory
Therapeutic | Products Name | Molecule / Composition | Type | Indications |
---|---|---|---|---|
Respiratory | Ambroxol Hydrochloride | 15 mg/ 5 ml 30 mg/ 5 ml | Syrup | Indicated for the treatment of respiratory disorders associated with excessive mucus production, as in COPD, bronchitis, and asthma, it acts as a mucolytic agent. |
Respiratory | Ambroxol + Clenbuerol | 7.5 mg + 0.005 mg | Syrup | Indicated for the management of respiratory conditions characterized by excessive mucus production and bronchospasm, such as COPD and asthma. Ambroxol acts as a mucolytic agent Clenbuterol provides bronchodilation and improves airflow by relaxing airway smooth muscles. |
Respiratory | Ambroxol + Terbutaline + Guaiphenesin + Menthol | 30 mg + 1.25 mg + 50 mg + 1 mg | Expectorant | Indicated for the management of respiratory conditions characterized by excessive mucus production and bronchospasm, such as bronchitis and asthma. |
Anti Microbial
Therapeutic | Products Name | Molecule / Composition | Type | Indications |
---|---|---|---|---|
Anti Microbial | Azithromycin | 100 mg/ 5 ml 200 mg/ 5 ml | Suspension | Indicated for the treatment of various bacterial infections, including respiratory tract infections, skin infections etc., it works by inhibiting bacterial protein synthesis. |
Anti Microbial | Azithromycin | 250 mg 500 mg | Tablet | Indicated for the treatment of various bacterial infections, including respiratory tract infections, skin infections etc., it works by inhibiting bacterial protein synthesis. |
Anti Microbial | Ciprofloxacin | 500 mg 750 mg | Tablet | Indicated for the treatment of various bacterial infections, including urinary tract infections, respiratory tract infections, etc. |
Anti Microbial | Levofloxacin | 500 mg 750 mg | Tablet | Indicated for the treatment of a range of bacterial infections, including respiratory tract infections (such as pneumonia and bronchitis), urinary tract infections, and skin and soft tissue infections caused by susceptible organisms. |
Anti Microbial | Lomefloxacin | 400 mg | Tablet | Indicated for the treatment of a range of bacterial infections, including urinary tract infections, respiratory tract infections, and gastrointestinal infections caused by susceptible strains of bacteria. |
Anti Microbial | Metronidazole | 1% | Gel | Indicated for the topical treatment of inflammatory lesions associated with rosacea, as well as for the management of various anaerobic bacterial infections and certain protozoal infections of the skin. |
Anti Microbial | Metronidazole | 200 mg/ 5 ml | Suspension | Indicated for the treatment of various anaerobic bacterial infections, protozoal infections such as amoebiasis and giardiasis, and for the management of infections caused by Clostridium difficile. |
Anti Microbial | Metronidazole | 400 mg | Tablet | Indicated for the treatment of various anaerobic bacterial infections, protozoal infections such as amoebiasis and giardiasis, and for the management of infections caused by Clostridium difficile. |
Anti Microbial | Moxifloxacin | 400 mg | Tablet | Indicated for the treatment of various bacterial infections, including respiratory tract infections, skin and soft tissue infections, and intra-abdominal infections caused by susceptible strains. |
Anti Microbial | Olfloxacin | 200 mg | Tablet | Indicated for the treatment of various bacterial infections, including respiratory tract infections, urinary tract infections, and skin and soft tissue infections caused by susceptible microorganisms. |
Anti Microbial | Ornidazole | 500 mg | Tablet | Indicated for the treatment of various anaerobic bacterial and protozoal infections, including amoebic dysentery, giardiasis, and bacterial vaginosis. |
Anti Microbial | Phenazopyridine + Nitrofurantoin | 100 mg + 50 mg | Tablet | Indicated for the symptomatic relief of urinary tract infections (UTIs) and for the treatment of uncomplicated cystitis, Phenazopyridine acts as a urinary analgesic, providing relief from dysuria and urgency by soothing the urinary tract lining Nitrofurantoin serves as an antibacterial agent. |
Anti Microbial | Tinidazole | 500 mg | Tablet | Indicated for the treatment of various protozoal and anaerobic bacterial infections, including giardiasis, amoebiasis, and bacterial vaginosis. |
CNS
Therapeutic | Products Name | Molecule / Composition | Type | Indications |
---|---|---|---|---|
CNS | Baclofene | 10mg 25 mg | Tablet | Indicated for the management of spasticity resulting from conditions such as multiple sclerosis or other neurological disorders, by reducing muscle tone and alleviating muscle spasms, thereby improving mobility. |
CNS | Pregabalin | 75 mg 150 mg 300 mg | Capsule | Indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia. Additionally, it is used as an adjunctive therapy for the treatment of partial-onset seizures in adults with epilepsy. |
CNS | Tizanidine | 4 mg | Tablet | Indicated for the management of spasticity associated with conditions such as multiple sclerosis and spinal cord injury. |
CNS | Tofisopam | 50 mg | Tablet | Indicated for the treatment of anxiety disorders and for the management of associated somatic symptoms, such as muscle tension and sleep disturbances. |
Calcium Supplementary
Therapeutic | Products Name | Molecule / Composition | Type | Indications |
---|---|---|---|---|
Calcium Supplementary | Calcium Dobesilate | 500 mg | Capsule | Indicated for the treatment of chronic venous insufficiency, diabetic retinopathy, and hemorrhoidal disease. |
Anti Histaminines
Therapeutic | Products Name | Molecule / Composition | Type | Indications |
---|---|---|---|---|
Anti Histamines | Cetirizine Hydrochloride | 10 mg | Tablet | Indicated for the relief of symptoms associated with allergic rhinitis, such as sneezing, rhinorrhea, and pruritus, as well as for the management of chronic idiopathic urticaria. |
Anti Histamines | Cetirizine + Dextromethorphan + Phenylephrine + Menthol | 5 mg + 10 mg + 5 mg + 1.5 mg | Syrup | Indicated for the symptomatic relief of respiratory conditions such as allergic rhinitis, common cold, and sinusitis. Cetirizine reduces allergy symptoms Dextromethorphan acts as a cough suppressant Phenylephrine provides decongestant effects Menthol offers a soothing sensation. |
Anti Histamines | Cetirizine + Phenylephrine + Paracetamol | 5 mg + 5 mg + 500 mg | Tablet | Indicated for the symptomatic relief of allergic rhinitis, sinusitis, and associated conditions such as colds and flu etc., Cetirizine acts by reducing allergy symptoms Phenylephrine acts as a decongestant Paracetamol provides analgesic and antipyretic effects. |
Anti Histamines | Clemastine | 1 mg | Tablet | Indicated for the relief of symptoms associated with allergic rhinitis and chronic urticaria, including sneezing, runny nose, and itching. |
Anti Histamines | Desloratidine | 5 mg | Tablet | Indicated for the relief of symptoms associated with allergic rhinitis, such as sneezing, runny or itchy nose, and itchy or watery eyes, as well as for the treatment of chronic idiopathic urticaria (hives). |
Anti Histamines | Guaiphenesin + Dextromethorphan + Pseudophedran | 50 mg + 5 mg + 15 mg | Syrup | Indicated for the symptomatic relief of cough and congestion associated with respiratory tract infections, such as bronchitis and colds. Guaifenesin acts as an expectorant Dextromethorphan serves as a cough suppressant Pseudoephedrine is a decongestant. |
Anti Histamines | Levocetirizine | 5 mg | Tablet | Indicated for the relief of symptoms associated with allergic rhinitis, such as sneezing, runny or itchy nose, and itchy or watery eyes, as well as for the management of chronic urticaria (hives). |
Anti Histamines | Levocetirizine + Montelukast | 5 mg + 10 mg | Tablet | Indicated for the management of allergic rhinitis and asthma, particularly in patients with coexisting conditions. Levocetirizine effectively alleviates allergy symptoms Montelukast reduces airway inflammation and bronchoconstriction. |
Anti Histamines | Loratidine | 5 mg | Tablet | Indicated for the relief of symptoms associated with allergic rhinitis and chronic idiopathic urticaria, including sneezing, runny nose, and itching. |
Anti Histamines | Paracetamol + Chlorpheniramine + Phenylephrine + Caffeine | 500 mg + 2 mg + 5 mg + 15 mg | Tablet | Indicated for the symptomatic relief of headaches, nasal congestion, and other symptoms associated with colds and allergies. Paracetamol acts as an analgesic and antipyretic Chlorpheniramine alleviates allergy symptoms Phenylephrine serves as a decongestant to reduce nasal swelling Caffeine enhances the analgesic effect of paracetamol. |
Anti Histamines | Phenylephrine + Paracetamol + Caffeine + Ascorbic acid | 5 mg + 750 mg + 25 mg + 30 mg | Sachet | Indicated for the symptomatic relief of headaches, nasal congestion, and associated symptoms of colds and flu, Phenylephrine acts as a decongestant Paracetamol provides analgesic and antipyretic effects, reducing pain and fever Caffeine enhances the analgesic effect of paracetamol Ascorbic acid serves as an antioxidant that may support immune function. |
Anti Histamines | Salbutamol + Bromhexine + Guaphenesin | 1 mg + 2 mg + 50 mg | Syrup | Indicated for the management of respiratory conditions characterized by bronchospasm and excessive mucus production, such as asthma, COPD, and bronchitis. Salbutamol provides bronchodilation Bromhexine functions as a mucolytic agent Guaifenesin serves as an expectorant. |
Anti Histamines | Salbutamol + Bromhexine + Guaphenesin + Menthol | 1 mg + 2 mg + 50 mg + 0.5 mg | Syrup | Indicated for the management of respiratory conditions characterized by bronchospasm and excessive mucus production, such as bronchitis and asthma. Salbutamol provides bronchodilation Bromhexine serves as a mucolytic agent Guaifenesin helps to reduce mucus viscosity Menthol provides a soothing effect. |
Endrocrinology
Therapeutic | Products Name | Molecule / Composition | Type | Indications |
---|---|---|---|---|
Endocrinology | Glibenclamide | 3.5 mg 5 mg | Tablet | Indicated for the management of type 2 diabetes mellitus in adults, typically as part of a comprehensive treatment plan that includes diet and exercise, glibenclamide stimulates insulin secretion. |
Endocrinology | Glibenclamide + Metformin Hydrochloride | 5 mg + 500 mg 5 mg + 1000 mg | Tablet | Indicated for the management of type 2 diabetes mellitus in patients who require dual therapy to achieve optimal glycemic control. Glibenclamide stimulates insulin secretion from the pancreatic beta cells Metformin enhances insulin sensitivity and reduces hepatic glucose production |
Endocrinology | Gliclazide | 80 mg | Tablet | Indicated for the management of type 2 diabetes mellitus in adults, typically as part of a comprehensive treatment plan that includes diet and exercise, glibenclamide stimulates insulin secretion. |
Endocrinology | Glimepiride | 1 mg 2 mg | Tablet | Indicated for the management of type 2 diabetes mellitus in adults, typically used as an adjunct to diet and exercise to improve glycemic control.Glimepiride functions by increasing insulin secretion. |
Endocrinology | Glipizide | 5 mg | Tablet | Indicated for the management of type 2 diabetes mellitus in adults, as an adjunct to diet and exercise to improve glycemic control. |
Endocrinology | Metformin | 500 mg 750 mg 850 mg 1000 mg | Tablet | Indicated for the management of type 2 diabetes mellitus, particularly in patients who are overweight or obese, as part of a comprehensive treatment plan that may include diet and exercise. |
Endocrinology | Pancreatin | 10000 IU 20000 IU 25000 IU 40000 IU | Capsule | Indicated for the management of exocrine pancreatic insufficiency due to conditions such as cystic fibrosis, chronic pancreatitis, or pancreatic surgery. |
Endocrinology | Pioglitazone + Metformin | 15 mg + 500 mg 15 mg + 800 mg | Tablet | Indicated for the management of type 2 diabetes mellitus in adults, particularly in patients who are unable to achieve adequate glycemic control with diet and exercise alone Pioglitazone enhances insulin sensitivity in peripheral tissues Metformin decreases hepatic glucose production and increases peripheral glucose uptake. |
Endocrinology | Prasugrel | 5 mg 10 mg | Tablet | Indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome (ACS) who are undergoing percutaneous coronary intervention (PCI). |
Endocrinology | Prednisolone | 15 mg/ 5 ml | Syrup | Indicated for the management of various inflammatory and autoimmune conditions, including asthma, allergic reactions, rheumatoid arthritis, and certain hematological disorders. |
Endocrinology | Raloxifene Hydrochloride | 60 mg | Tablet | Indicated for the prevention and treatment of osteoporosis in postmenopausal women, as well as for the reduction of invasive breast cancer risk in women with osteoporosis or at high risk for breast cancer. |
Endocrinology | Sitagliptin Phosphate | 25 mg 50 mg 100 mg | Tablet | Indicated for the management of type 2 diabetes mellitus in adults, as an adjunct to diet and exercise to improve glycemic control. |
Endocrinology | Vildagliptin + Metformin | 50 mg + 500 mg 50 mg + 850 mg | Tablet | Indicated for the management of type 2 diabetes mellitus in adults, particularly in patients who have not achieved adequate glycemic control with metformin alone. Vildagliptin enhances glucose-dependent insulin secretion and suppresses glucagon release, while metformin works by improving insulin sensitivity and reducing hepatic glucose production, leading to better overall glycemic control and a reduced risk of diabetes-related complications. |
Endocrinology | Voglibose | 0.2 mg 0.3 mg | Tablet | Indicated for the management of postprandial hyperglycemia in patients with type 2 diabetes mellitus, Voglibose works by reducing the rise in blood glucose levels following meals and improving overall glycemic control when used in conjunction with other antidiabetic medications. |
Endocrinology | Voglibose + Metformin | 0.2 mg + 500 mg 0.3mg + 500mg | Tablet | Indicated for the management of type 2 diabetes mellitus in adults, particularly in patients with insufficient glycemic control on diet and exercise alone. Voglibose delays carbohydrate absorption in the intestines, while metformin improves insulin sensitivity and reduces hepatic glucose production. |
Immuno Suppressant
Therapeutic | Products Name | Molecule / Composition | Type | Indications |
---|---|---|---|---|
Immunosuppressant | Mycophenolate mofetil | 250 mg 500 mg | Tablet | Indicated for the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac, or hepatic transplants, typically used in combination with other immunosuppressants. |
Immunosuppressant | Sirolimus | 0.5 mg 2 mg | Tablet | Indicated for the prevention of organ rejection in kidney transplant recipients, often used in combination with other immunosuppressive agents, Sirolimus works by reducing the immune response and the risk of transplant rejection while promoting graft survival. |
Immunosuppressant | Tacrolimus | 0.5 mg 1 mg 5 mg | Capsule | Indicated for the prevention of organ transplant rejection in patients undergoing renal, liver, or heart transplantation, as well as for the treatment of moderate to severe atopic dermatitis when conventional therapies are insufficient. Tacrolimus reduces the immune response and the risk of graft rejection or exacerbation of skin disorders. |
Urology
Therapeutic | Products Name | Molecule / Composition | Type | Indications |
---|---|---|---|---|
Urology | Tamsulosin Prolonged- Release | 0.4 mg | Tablet | Indicated for the treatment of benign prostatic hyperplasia (BPH) in men, helping to relieve urinary symptoms associated with this condition, thereby improving urinary flow and reducing symptoms such as urgency, frequency, and nocturia |
Urology | Tamsulosin SR | 0.2 mg 0.4 mg | Tablet | Indicated for the treatment of benign prostatic hyperplasia (BPH) in men, helping to relieve urinary symptoms associated with this condition, thereby improving urinary flow and reducing symptoms such as urgency, frequency, and nocturia |
Urology | Tamsulosin HCl + Dutaseride SR | 0.4 mg + 0.5 mg | Capsule | Indicated for the treatment of benign prostatic hyperplasia (BPH) in men, helping to relieve urinary symptoms associated with this condition, thereby improving urinary flow and reducing symptoms such as urgency, frequency, and nocturia |
Cardiovascular
Therapeutic | Products Name | Molecule / Composition | Type | Indications |
---|---|---|---|---|
Cardiovascular | Amlodipine | 5 mg 10 mg | Tablet | Indicated for the treatment of hypertension and angina pectoris, by reducing peripheral resistance, and improved myocardial oxygen delivery. |
Cardiovascular | Amlodipine + Atorvastatin | 5 mg + 10 mg | Tablet | Indicated for patients with coexisting hypertension and dyslipidemia, as well as for reducing the risk of cardiovascular events in patients with multiple risk factors. Amlodipine lowers blood pressure through vasodilation Atorvastatin reduces cholesterol levels and stabilizes atherosclerotic plaques. |
Cardiovascular | Amlodipine + Lisinopril | 5 mg + 5 mg | Tablet | Indicated for the management of hypertension in patients who require multiple drugs to achieve blood pressure control. Amlodipine promotes vasodilation Lisinopril reduces vascular resistance and improved blood pressure regulation. |
Cardiovascular | Atorvastatin | 10 mg 20 mg 40 mg 80 mg | Tablet | Indicated for the management of dyslipidemia, specifically to lower elevated levels of low-density lipoprotein cholesterol (LDL-C) and triglycerides, as well as to increase high-density lipoprotein cholesterol (HDL-C). It is also used in the primary and secondary prevention of cardiovascular disease by reducing the risk of myocardial infarction, stroke, and other cardiovascular events. |
Cardiovascular | Atorvastatin + Aspirin | 10 mg + 75 mg 10 mg + 150 mg | Capsule | Indicated for the secondary prevention of cardiovascular events in patients with established atherosclerotic cardiovascular disease or those at high risk, thereby stabilizing atherosclerotic plaques. |
Cardiovascular | Atorvastatin + Aspirin + Ramipril | 10 mg + 75 mg + 5 mg | Tablet | Indicated for the secondary prevention of cardiovascular events in patients with established atherosclerotic cardiovascular disease or those at high risk. Atorvastatin reduces low-density lipoprotein cholesterol (LDL-C) levels and stabilizes atherosclerotic plaques Aspirin provides antiplatelet effects Ramipril lowers blood pressure and reduces cardiac workload. |
Cardiovascular | Bisoprolol Fumarate | 2.5 mg 5 mg 10 mg | Tablet | Indicated for the management of hypertension and the treatment of stable chronic heart failure, as well as for the reduction of the risk of cardiovascular events in patients with ischemic heart disease. |
Cardiovascular | Bosentan | 62.5 mg 125 mg | Tablet | Indicated for the treatment of pulmonary arterial hypertension (PAH), by causing vasodilation and reduced pulmonary vascular resistance. |
Cardiovascular | Clopidogrel | 75 mg | Tablet | Indicated for the prevention of atherothrombotic events in patients with established cardiovascular disease, including those with a history of myocardial infarction, stroke, or peripheral arterial disease, it helps in preventing platelet activation and aggregation, which reduces the risk of thrombus formation in arterial circulation. |
Cardiovascular | Eplerenone | 25 mg 50 mg | Tablet | Indicated for the treatment of hypertension and for the management of heart failure in patients with reduced ejection fraction following a myocardial infarction. |
Cardiovascular | Fosinopril Sodium | 10 mg 20 mg 40 mg | Tablet | Indicated for the management of hypertension and the treatment of heart failure. |
Cardiovascular | Gemfibrozil | 600 mg | Tablet | Indicated for the management of dyslipidemia, specifically for lowering elevated triglyceride levels and increasing high-density lipoprotein cholesterol (HDL-C) in patients at risk for cardiovascular disease. |
Cardiovascular | Hydrocortisone | 10 mg 20 mg | Tablet | Indicated for the replacement therapy in adrenocortical insufficiency, such as Addison’s disease, and for the management of various inflammatory and autoimmune disorders, including rheumatoid arthritis and systemic lupus erythematosus. |
Cardiovascular | Irbesartan | 150 mg | Tablet | Indicated for the management of hypertension and the treatment of diabetic nephropathy in patients with type 2 diabetes mellitus. |
Cardiovascular | Lisinopril | 5 mg 10 mg 20 mg | Tablet | Indicated for the treatment of hypertension, heart failure, and for the reduction of the risk of myocardial infarction and stroke in patients with cardiovascular disease. |
Cardiovascular | Lisinopril + Hydrochlorothiazide | 10 mg + 12.5 mg | Tablet | Indicated for the management of hypertension, providing synergistic effects to lower blood pressure effectively. Lisinopril leads to vasodilation and decreased blood volume Hydrochlorothiazide promotes diuresis and reduces fluid retention. |
Cardiovascular | Losartan Potassium | 50 mg 100 mg | Tablet | Indicated for the management of hypertension and for the reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy. |
Cardiovascular | Losartan Potassium + Hydrochlorothiazide | 50 mg + 12.5 mg | Tablet | Indicated for the management of hypertension in adult patients. Losartan leads to vasodilation and decreased blood pressure Hydrochlorothiazide promotes diuresis and reduces blood volume. |
Cardiovascular | Moxonidine | 0.2 mg 0.3 mg 0.4 mg | Tablet | Indicated for the treatment of essential hypertension, moxonidine reduces peripheral vascular resistance and lowers blood pressure, thereby improving cardiovascular outcomes in hypertensive patients. |
Cardiovascular | Nimodipine Controlled Release | 60 mg | Tablet | Indicated for the improvement of neurological outcomes following subarachnoid hemorrhage (SAH) due to aneurysmal rupture. |
Cardiovascular | Olmesartan Medoxomil | 20 mg | Tablet | Indicated for the treatment of hypertension, either alone or in combination with other antihypertensive agents, olmesartan medoxomil causes vasodilation, reduced peripheral resistance, and subsequently lowering blood pressure. |
Cardiovascular | Ramipril | 10 mg | Tablet | Indicated for the management of hypertension, the treatment of heart failure following myocardial infarction, and for the reduction of cardiovascular risk in high-risk patients. |
Cardiovascular | Ramipril + Hydrochlorothiazide | 2.5 mg + 12.5 mg 10 mg + 25 mg | Tablet | Indicated for the management of hypertension, particularly in patients whose blood pressure is not adequately controlled with monotherapy. |
Cardiovascular | Ranolazine Extended Release | 500 mg 1000 mg | Tablet | Indicated for the treatment of chronic stable angina in adults, typically in combination with other antianginal agents. |
Cardiovascular | Rosuvastatin | 5 mg 10 mg 20 mg 40 mg | Tablet | Indicated for the management of dyslipidemia, specifically for lowering elevated levels of low-density lipoprotein cholesterol (LDL-C) and triglycerides, and for raising high-density lipoprotein cholesterol (HDL-C) levels. |
Cardiovascular | Telmisartan | 20 mg 40 mg 80 mg | Tablet | Indicated for the management of hypertension and the reduction of cardiovascular risk in patients with established cardiovascular disease or those at high risk. |
Cardiovascular | Telmisartan + Hydrochlorothiazide | 80 mg + 12.5 mg | Tablet | Indicated for the management of hypertension in adults Telmisartan reduces blood pressure by inhibiting the vasoconstrictive effects of angiotensin II Hydrochlorothiazide, promotes natriuresis and reduces blood volume. |
Cardiovascular | Telmisartan + Hydrochlorothiazide + Amlodipine | 20 mg + 12.5 mg + 5 mg | Tablet | Indicated for the management of hypertension in adults, particularly in patients whose blood pressure is inadequately controlled by monotherapy. Telmisartan works by inhibiting vasoconstriction Hydrochlorothiazide promotes natriuresis Amlodipine induces vasodilation |
Cardiovascular | Trimetazidine | 20 mg 35 mg | Tablet | Indicated for the treatment of stable angina pectoris and for the management of symptoms associated with microvascular angina Trimetazidine improves myocardial efficiency and reducing the frequency of angina episodes in affected patients. |
Cardiovascular | Troxerutin | 2% | Gel | Indicated for the topical treatment of conditions associated with venous insufficiency, such as varicose veins, chronic venous insufficiency, and hemorrhoids. Troxerutin exhibits anti-inflammatory, antioxidant, and venoprotective properties. |
Pulmonary
Therapeutic | Products Name | Molecule / Composition | Type | Indications |
---|---|---|---|---|
Pulmonary | Bedaquiline | 100 mg | Tablet | Indicated for the treatment of multidrug-resistant tuberculosis (MDR-TB) by disrupting energy production in Mycobacterium tuberculosis, thereby reducing bacterial viability. |
Pulmonary | Clofazimine | 50 mg 100 mg | Capsule | Indicated for the treatment of leprosy in combination with other antileprosy agents and for the management of multidrug-resistant tuberculosis (MDR-TB), clofazimine exhibits antibacterial and anti-inflammatory properties. |
Pulmonary | Cycloserine | 125 mg 250 mg 500 mg | Capsule | Indicated for the treatment of multidrug-resistant tuberculosis (MDR-TB) when other effective anti-tubercular agents cannot be used, it exerts bactericidal effects against Mycobacterium tuberculosis. |
Pulmonary | Cycloserine + Pyridoxine | 250 mg + 50 mg | Tablet | Indicated for the treatment of multidrug-resistant tuberculosis (MDR-TB) as part of a comprehensive therapeutic regimen. Cycloserine acts as a bactericidal agent Pyridoxine (vitamin B6) is included to mitigate the risk of neurotoxic side effects associated with cycloserine. |
Pulmonary | Ethambutol | 400 mg | Tablet | Indicated as part of a multidrug regimen for the treatment of pulmonary and extrapulmonary tuberculosis. |
Pulmonary | Ethionamide | 250 mg | Tablet | Indicated for the treatment of multidrug-resistant tuberculosis (MDR-TB) as part of a comprehensive therapeutic regimen, leading to the bactericidal activity against the pathogen. |
Pulmonary | Isoniazid | 100 mg 200 mg 300 mg | Tablet | Indicated for the treatment and prevention of tuberculosis (TB), particularly in cases of active pulmonary TB and as part of a multidrug regimen for latent TB infection, isoniazid exerts bactericidal effects against Mycobacterium tuberculosis. |
Pulmonary | Linezolid | 200 mg 400 mg 600 mg | Tablet | Indicated for the treatment of serious infections caused by gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE). |
Pulmonary | Prothionamide | 250 mg | Tablet | Indicated for the treatment of multidrug-resistant tuberculosis (MDR-TB) as part of a comprehensive antitubercular regimen, prothionamide exerts its bactericidal effect. |
Pulmonary | Pyrazinamide | 500 mg | Tablet | Indicated for the treatment of tuberculosis (TB) as part of a multi-drug regimen, particularly in the initial phase of anti-TB therapy. |
Pulmonary | Rifabutin | 150 mg 300 mg | Capsule | Indicated for the prevention and treatment of mycobacterial infections, particularly in patients with HIV who are at high risk of developing Mycobacterium avium complex (MAC) disease. |
Pulmonary | Rifapentine | 150 mg | Tablet | Indicated for the treatment of tuberculosis (TB) in combination with other antitubercular agents. |
Pulmonary | Terizidone | 150 mg 250 mg 300 mg | Capsule | Indicated for the treatment of multidrug-resistant tuberculosis (MDR-TB) as part of a comprehensive regimen. Terizidone exhibits antibacterial activity by inhibiting mycobacterial cell wall synthesis and function, thereby reducing the viability of Mycobacterium tuberculosis. |
Pulmonary | Terizidon + Pyridoxine | 250 mg + 10 mg 300 mg + 10 mg 300 mg + 20 mg | Capsule | Indicated for the treatment of multidrug-resistant tuberculosis (MDR-TB) as part of a comprehensive anti-tuberculosis regimen. Terizidone acts as an anti-tubercular agent Pyridoxine mitigates the risk of peripheral neuropathy, a common side effect associated with terizidone therapy. |